Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature - PubMed (original) (raw)

Review

Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature

Kelly E Courtney et al. Drug Alcohol Depend. 2014.

Abstract

Background: Despite initial reports of a decline in use in the early 2000s, methamphetamine remains a significant public health concern with known neurotoxic and neurocognitive effects to the user. The goal of this review is to update the literature on methamphetamine use and addiction since its assent to peak popularity in 1990s.

Methods: We first review recent epidemiological reports with a focus on methamphetamine accessibility, changes in use and disorder prevalence rates over time, and accurate estimates of the associated burden of care to the individual and society. Second, we review methamphetamine pharmacology literature with emphasis on the structural and functional neurotoxic effects associated with repeated use of the drug. Third, we briefly outline the findings on methamphetamine-related neurocognitive deficits as assessed via behavioral and neuroimaging paradigms. Lastly, we review the clinical presentation of methamphetamine addiction and the evidence supporting the available psychosocial and pharmacological treatments within the context of an addiction biology framework.

Conclusion: Taken together, this review provides a broad-based update of the available literature covering methamphetamine research over the past two decades and concludes with recommendations for future research.

Keywords: Addiction; Medication development; Methamphetamine; Stimulants.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: LAR is a paid consultant for GSK. No other conflicts of interest declared.

Cited by

PHEOCHROMOCYTOMA CONCEALED BY CHRONIC METHAMPHETAMINE ABUSE.
Constantinescu G, Leike S, Gruber M, Langton K, Kunath C, Peitzsch M, Deinum J, Eisenhofer G, Lenders J. Constantinescu G, et al. AACE Clin Case Rep. 2020 Sep 21;6(5):e212-e216. doi: 10.4158/ACCR-2019-0601. eCollection 2020 Sep-Oct. AACE Clin Case Rep. 2020. PMID: 32984523 Free PMC article.
Characterising the increasing prevalence of crystal methamphetamine use in Vancouver, Canada, from 2006-2017: A gender-based analysis.
Bach P, Hayashi K, Milloy MJ, Nosova E, Kerr T, Wood E, Fairbairn N. Bach P, et al. Drug Alcohol Rev. 2020 Nov;39(7):932-940. doi: 10.1111/dar.13126. Epub 2020 Jul 14. Drug Alcohol Rev. 2020. PMID: 32666650 Free PMC article.
Methamphetamine-induced region-specific transcriptomic and epigenetic changes in the brain of male rats.
Miao B, Xing X, Bazylianska V, Madden P, Moszczynska A, Zhang B. Miao B, et al. Commun Biol. 2023 Sep 27;6(1):991. doi: 10.1038/s42003-023-05355-3. Commun Biol. 2023. PMID: 37758941 Free PMC article.
DFT-D4 Insight into the Inclusion of Amphetamine and Methamphetamine in Cucurbit[7]uril: Energetic, Structural and Biosensing Properties.
Litim A, Belhocine Y, Benlecheb T, Ghoniem MG, Kabouche Z, Ali FAM, Abdulkhair BY, Seydou M, Rahali S. Litim A, et al. Molecules. 2021 Dec 10;26(24):7479. doi: 10.3390/molecules26247479. Molecules. 2021. PMID: 34946564 Free PMC article.
Methamphetamine Activates Toll-Like Receptor 4 to Induce Central Immune Signaling within the Ventral Tegmental Area and Contributes to Extracellular Dopamine Increase in the Nucleus Accumbens Shell.
Wang X, Northcutt AL, Cochran TA, Zhang X, Fabisiak TJ, Haas ME, Amat J, Li H, Rice KC, Maier SF, Bachtell RK, Hutchinson MR, Watkins LR. Wang X, et al. ACS Chem Neurosci. 2019 Aug 21;10(8):3622-3634. doi: 10.1021/acschemneuro.9b00225. Epub 2019 Jul 17. ACS Chem Neurosci. 2019. PMID: 31282647 Free PMC article.

References

1. Acquas E, Meloni M, Di Chiara G. Blockade of delta-opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release. Eur J Pharmacol. 1993;230:239–241. - PubMed
1. American Psychiatric Association. Diagnostic And Statistical Manual Of Mental Disorders. American Psychiatric Association; Washington, DC: 1994.
1. American Psychiatric Association. Diagnostic And Statistical Manual Of Mental Disorders. American Psychiatric Publishing; Arlington, VA: 2013.
1. Anderson AL, Li SH, Biswas K, McSherry F, Holmes T, Iturriaga E, Kahn R, Chiang N, Beresford T, Campbell J, Haning W, Mawhinney J, McCann M, Rawson R, Stock C, Weis D, Yu E, Elkashef AM. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend. 2012;120:135–141. - PMC - PubMed
1. Anggadiredja K, Sakimura K, Hiranita T, Yamamoto T. Naltrexone attenuates cue-but not drug-induced methamphetamine seeking: A possible mechanism for the dissociation of primary and secondary reward. Brain Res. 2004;1021:272–276. - PubMed

Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature - PubMed (original) (raw)